Page last updated: 2024-09-02

ramosetron and loperamide

ramosetron has been researched along with loperamide in 6 studies

Compound Research Comparison

Studies
(ramosetron)
Trials
(ramosetron)
Recent Studies (post-2010)
(ramosetron)
Studies
(loperamide)
Trials
(loperamide)
Recent Studies (post-2010) (loperamide)
19494831,358196488

Protein Interaction Comparison

ProteinTaxonomyramosetron (IC50)loperamide (IC50)
Cocaine esteraseHomo sapiens (human)5.7
Beta-2 adrenergic receptorHomo sapiens (human)3.005
ATP-dependent translocase ABCB1Homo sapiens (human)2.5
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 29.27
Cytochrome P450 2D6Homo sapiens (human)2
Histamine H2 receptorHomo sapiens (human)3.081
Sodium-dependent serotonin transporterHomo sapiens (human)2.202
Mu-type opioid receptorHomo sapiens (human)0.0014
D(3) dopamine receptorHomo sapiens (human)1.337
Delta-type opioid receptorHomo sapiens (human)0.896
Kappa-type opioid receptorHomo sapiens (human)3.125
5-hydroxytryptamine receptor 2BHomo sapiens (human)4.105
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.033
Sodium channel protein type 5 subunit alphaHomo sapiens (human)0.239
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.628

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ozaki, A; Sukamoto, T; Yoshidomi, M1
Akuzawa, S; Funatsu, T; Hirata, T; Keto, Y; Sasamata, M1
Akuzawa, S; Funatsu, T; Hirata, T; Keto, Y; Sasamata, M; Takeuchi, A1
Akuzawa, S; Funatsu, T; Hirata, T; Keto, Y; Miyata, K; Sasamata, M1
Akuzawa, S; Funatsu, T; Hirata, T; Keto, Y; Miyata, K; Nakata, M; Sasamata, M; Takeuchi, A1
Morgan, B1

Other Studies

6 other study(ies) available for ramosetron and loperamide

ArticleYear
Effect of the 5-hydroxytryptamine3 (5-HT3)-receptor antagonist KB-R6933 on experimental diarrhea models.
    Japanese journal of pharmacology, 1999, Volume: 80, Issue:1

    Topics: Animals; Antidiarrheals; Benzimidazoles; Diarrhea; Loperamide; Male; Mice; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists

1999
Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome.
    Journal of pharmacological sciences, 2007, Volume: 104, Issue:3

    Topics: Animals; Benzimidazoles; Carbazoles; Carbolines; Carrier Proteins; Colon; Defecation; Gastrointestinal Agents; Guinea Pigs; Humans; Ion Channels; Irritable Bowel Syndrome; Loperamide; Male; Muscle, Smooth; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Restraint, Physical; Serotonin Antagonists; Stress, Psychological

2007
Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
    European journal of pharmacology, 2007, Nov-14, Volume: 573, Issue:1-3

    Topics: Animals; Behavior, Animal; Benzimidazoles; Carbazoles; Carbolines; Colon; Colonic Diseases, Functional; Conditioning, Psychological; Corticotropin-Releasing Hormone; Defecation; Disease Models, Animal; Dose-Response Relationship, Drug; Fear; Gastrointestinal Transit; Immobilization; Irritable Bowel Syndrome; Loperamide; Male; Peptide Fragments; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Stress, Psychological; Time Factors; Treatment Outcome

2007
Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents.
    Journal of pharmacological sciences, 2008, Volume: 106, Issue:2

    Topics: Animals; Antidiarrheals; Benzimidazoles; Conditioning, Classical; Defecation; Fear; Irritable Bowel Syndrome; Loperamide; Male; Parasympatholytics; Quinolizines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Stress, Physiological; Trimebutine

2008
Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats.
    European journal of pharmacology, 2008, Jun-10, Volume: 587, Issue:1-3

    Topics: Animals; Antidiarrheals; Benzimidazoles; Carbazoles; Carbolines; Colon; Corticotropin-Releasing Hormone; Defecation; Dose-Response Relationship, Drug; Injections, Intraventricular; Loperamide; Male; Pyridines; Rats; Rats, Wistar; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Water

2008
Drug development: A healthy pipeline.
    Nature, 2016, 05-19, Volume: 533, Issue:7603

    Topics: Animals; Benzimidazoles; Benzofurans; Bile Acids and Salts; Carbolines; Colesevelam Hydrochloride; Colestipol; Disease Models, Animal; Enteric Nervous System; Female; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; Loperamide; Lubiprostone; Male; Mice; Natriuretic Peptides; Peptides; Phenylalanine; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Rifamycins; Rifaximin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Visceral Pain

2016